
Mucopolysaccharidosis Type I Market To Witness Upsurge In Growth At A CAGR Of 8% During The Forecast Period (2025-2034) ...
(MENAFN- PR Newswire) The future of MPS I treatment is poised for significant advancements, driven by ongoing research and innovative therapies. Emerging therapies, such as stem cell gene therapy, IDUA Gene therapy, and Recombinant DNA, including OTL-203, …